The World Health Organization reports that ischaemic heart disease, also known as coronary artery disease, is the leading ...

University of Cambridge researchers have linked high levels of testosterone in the blood to a greater risk of coronary artery ...

Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion ...

New Clinical Indications Statement Expands Recommendations for Cardiac PET and Myocardial Blood Flow Quantification Based on the clinical and scientific evidence now available, there are no clinical ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

On Tuesday, Medtronic announced intent to acquire CathWorks, an Israel-based medical technology company, for $585 million.

Catheter-based procedures are preferred over traditional surgery. The global interventional cardiology devices market is ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

A late-breaking study drawing on more than 15 years of national outcomes data from the STS Adult Cardiac Surgery Database ...

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...

A new expert opinion from the Society for Cardiovascular Angiography & Interventions (SCAI) examines the evolving role of angiography-derived physiology (ADP), a wire-free method for coronary ...

The technology involves surgical endovascular treatment for patients who develop atherosclerotic plaques in their blood ...